semaglutide 2.65 mg/ml + levocarnitine 100 (Wegovy) 💉📉 Uncontrolled diabetes despite treatment?

Neither program guarantees results nobody legitimate does and both require honest conversation with a licensed clinician about the boxed warning for thyroid C-cell tumors that applies to both semaglutide and tirzepatide based on rodent studies, plus the standard GLP-1 side-effect profile (nausea, vomiting, diarrhea, constipation, abdominal pain, headache

Call us at 509-392-5007 to book your consultation today

I find that this medication increases insulin secretion and decreases glucagon release in response to meals

Additional research on the use of GLP-1 in patients with sepsis may further elucidate its anti-inflammatory properties and spur human studies